A Material Transfer Agreement (MTA) is a legal document governing the transfer of physical research materials between organizations, such as biospecimens, cell lines, reagents, or other biological materials.
MTAs define permitted use, ownership, intellectual property terms, publication rights, and handling requirements to protect both parties and ensure responsible stewardship. In clinical research, MTAs support compliant specimen sharing by clarifying chain of custody, storage conditions, and restrictions on secondary use. They also help align specimen use with consent terms and institutional policies, especially when materials originate from participants. Well-managed MTAs reduce risk, support traceability, and strengthen documentation for audits and inspections.